Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Feasibility of Night Respite Care for Postpartum Mothers With Substance Use Disorder in Residential Treatment Programs

NCT05746507 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05746507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05746507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Feasibility of Night Respite Care for Postpartum Mothers With Substance Use Disorder in Residential Treatment Programs
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 20, 2022
Completion date
April 30, 2025
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

maternal drugs affecting fetus, neonatal opioid withdrawal, opioid use disorder, postpartum mood disturbance, sleep disorder